Project Details
Project Description
Monash Health HREC Ref: 14094X
| Status | Finished |
|---|---|
| Effective start/end date | 29/03/19 → 28/03/24 |
Keywords
- clinical trial
- treatment efficacy
- breast cancer
- endocrine therapy
Clinical Trial Phase
- Phase III (a & b)
Multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of Fulvestrant (Faslodex) with or without pd-0332991 (Palbociclib) +/- Goserelin in women with hormone receptor-positive, HER2-negative metastatic breast cancer whose disease progressed after prior endocrine therapy
- Harris, Marion (Primary Chief Investigator (PCI))
Project: Research